Raymond James raises Fulgent Genetics stock price target to $36 on strong performance
Investing.com - Truist Securities lowered its price target on Wingstop (NASDAQ:WING) to $365.00 from $400.00 on Wednesday while maintaining a Buy rating on the stock. Despite the reduction, Truist’s target remains well above the current trading price of $248.21 and higher than the average analyst target, with InvestingPro data showing analyst targets ranging from $185 to $430.
The price target reduction follows Wingstop’s third-quarter 2025 results, which included a same-store sales miss and an adjusted EBITDA beat, according to the research firm.
Wingstop has lowered its same-store sales guidance, prompting Truist to reduce its estimates despite maintaining its positive long-term outlook on the company.
Truist Securities expects Wingstop’s sales drivers—including a new ad campaign, "Smart Kitchen" initiative, and upcoming loyalty plan—to increasingly offset growing macroeconomic pressures, potentially leading to a "sharp SSS recovery" in 2026.
The firm noted that Wingstop franchisees continue to open new stores aggressively despite economic uncertainty, resulting in another increase in 2025 development guidance and strong initial guidance for 2026.
In other recent news, Wingstop reported its third-quarter 2025 financial results, posting earnings per share of $1.09, which surpassed analyst expectations of $0.93. Despite this earnings beat, the company’s revenue came in at $175.5 million, slightly below the forecast of $187.37 million. The earnings surprise was driven by favorable general and administrative expenses and strong unit growth, although same-store sales declined by 5.6%. Analysts have adjusted their price targets for Wingstop following these results. Bernstein lowered its target to $350, citing broadening consumer softness despite the company’s record adjusted EBITDA growth of 18.6%. Raymond James reduced its target to $325, attributing the adjustment to macroeconomic pressures affecting lower and middle-income consumers. BMO Capital set a new target of $280, focusing on a softer comparable sales outlook. These developments reflect the mixed reactions from analysts despite Wingstop’s earnings performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.